Skip to main content
Smart Investors Daily
ProShares UltraShort Nasdaq Biotechnology logo

NASDAQ · BIS

ProShares UltraShort Nasdaq Biotechnology

Financial Services · Asset Management

$11.63

Up+$0.23 (+2.06%)

Updated Nov 20, 2026, 6:18 AM

SID Score

4.8/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
1.99M
P/E ratio
—
Dividend yield
5.17%
52-week range
$7.95 – $18.50
Volume
2.76K
Avg. volume
13.8K

Price performance · BIS

BIS price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Nov 19, 2026

BIS closed at $11.63 after 21 trading sessions, up 3.79% for the selected period.

Last close
$11.63
Period change
+3.79%
Period low
$10.00
Period high
$11.63
Daily close
View OHLC price history
BIS OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Nov 19, 2026$11.50$11.6344$11.42$11.63442.76K
Nov 18, 2026$11.2401$11.4041$11.1881$11.40412.37K
Nov 17, 2026$11.27$11.43$11.19$11.24963.3K
Nov 16, 2026$10.59$11.115$10.59$11.10919.58K
Nov 13, 2026$10.58$10.819$10.58$10.66042.25K
Nov 12, 2026$10.24$10.5577$10.24$10.544822.65K
Nov 11, 2026$10.175$10.27$10.0401$10.07926.57K
Nov 10, 2026$10.0624$10.255$10.0624$10.15998.36K
Nov 9, 2026$10.39$10.58$9.9217$9.996431.61K
Nov 6, 2026$10.9981$10.9981$10.53$10.562710.35K
Nov 5, 2026$10.0201$11.04$10.0201$11.0125.79K
Nov 4, 2026$10.16$10.48$10.06$10.06631.69K
Nov 3, 2026$10.50$10.73$10.2601$10.61975.36K
Nov 2, 2026$10.41$10.81$10.41$10.770621.82K
Oct 30, 2026$10.41$10.55$10.06$10.468813.07K
Oct 29, 2026$10.52$10.62$10.35$10.46487.97K
Oct 28, 2026$11.07$11.2582$10.6472$10.64726.59K
Oct 27, 2026$11.49$11.60$10.95$10.95610.4K
Oct 26, 2026$11.42$11.51$11.27$11.38728.28K
Oct 23, 2026$11.5099$11.56$11.36$11.460114.25K
Oct 22, 2026$11.14$11.41$10.911$11.209712.45K

Latest BIS news

The latest Smart Investors Daily articles mentioning BIS.

BIS research

Overview

Company profile and research snapshot.

Company profile

The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
Open full forecast

News briefing

No generated briefing is available yet.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.